| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.5705 | 
      | Human Intestinal Absorption | HIA+ | 0.8472 | 
      | Caco-2 Permeability | Caco2- | 0.7378 | 
      | P-glycoprotein Substrate | Substrate | 0.5369 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9437 | 
                                                     | Non-inhibitor | 0.9657 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9194 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6897 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8119 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9111 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6915 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.7367 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8076 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9467 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9208 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8800 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8757 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9736 | 
                                                                    | Non-inhibitor | 0.8978 | 
      | AMES Toxicity | Non AMES toxic | 0.8599 | 
      | Carcinogens | Non-carcinogens | 0.9569 | 
      | Fish Toxicity | High FHMT | 0.9476 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9710 | 
      | Honey Bee Toxicity | High HBT | 0.6589 | 
      | Biodegradation | Not ready biodegradable | 0.6562 | 
      | Acute Oral Toxicity | II | 0.5589 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6214 |